Viemed Non Operating Income Net Other from 2010 to 2026
| VMD Stock | USD 8.42 0.06 0.72% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 1.1 M | Current Value 1.1 M | Quarterly Volatility 510.9 K |
Check Viemed Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viemed Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 30.6 M, Total Revenue of 270.8 M or Gross Profit of 160.8 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.38 or PTB Ratio of 2.45. Viemed financial statements analysis is a perfect complement when working with Viemed Healthcare Valuation or Volatility modules.
Viemed | Non Operating Income Net Other | Build AI portfolio with Viemed Stock |
Analyzing Viemed Healthcare's Non Operating Income Net Other over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Non Operating Income Net Other has evolved provides context for assessing Viemed Healthcare's current valuation and future prospects.
Latest Viemed Healthcare's Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of Viemed Healthcare over the last few years. It is Viemed Healthcare's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viemed Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Viemed Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | 378,368 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 135.03 | |
| Mean Deviation | 468,241 | |
| Median | 0.00 | |
| Standard Deviation | 510,905 | |
| Sample Variance | 261B | |
| Range | 1.2M | |
| R-Value | 0.84 | |
| Mean Square Error | 83B | |
| R-Squared | 0.70 | |
| Significance | 0.000027 | |
| Slope | 84,755 | |
| Total Sum of Squares | 4.2T |
Viemed Non Operating Income Net Other History
About Viemed Healthcare Financial Statements
Viemed Healthcare stakeholders use historical fundamental indicators, such as Viemed Healthcare's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although Viemed Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Viemed Healthcare's assets and liabilities are reflected in the revenues and expenses on Viemed Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Viemed Healthcare. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | 1.1 M | 1.1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out the analysis of Viemed Healthcare Correlation against competitors. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Health Care Equipment & Supplies sector continue expanding? Could Viemed diversify its offerings? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viemed Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.1) | Earnings Share 0.34 | Revenue Per Share | Quarterly Revenue Growth 0.24 | Return On Assets |
Viemed Healthcare's market price often diverges from its book value, the accounting figure shown on Viemed's balance sheet. Smart investors calculate Viemed Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Viemed Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.